Table 1 Clinico-pathological characteristics of prostate samples

1

6 (3+3)

T2

T1^{d, e}

70

40

N1^{d, e}

40

0

-

N1-μD^e

T1-μD^e

2

9 (4+5)

T3a

T2^d

90

100

N2^d

50

0

-

-

-

3

5 (2+3)

T3a

T3^{d, e}

80

85

N3^{d, e}

40

0

-

N3-μD^e

T3-μD^e

4

7 (3+4)

T2

T4^d

60

80

N4^d

40

0

-

N4-μD^e

T4-μD^e

5

7 (4+3)

T2

T5^d

65

90

N5^d

45

0

-

-

-

6

9 (5+4)

T2

T6^{d, e}

80

100

N6^{d, e}

40

0

-

N6-μD^e

T6-μD^e

7

7 (3+4)

T3a

T7^{d, e}

80

100

N7^{d, e}

55

0

-

N7-μD^e

T7-μD^e

8

7 (3+4)

T2c

T8^d

80

100

-

-

-

S1

-

-

9

8 (3+5)

T2

T9^d

80

90

-

-

-

-

-

-

10

7 (3+4)

T3a

T10^d

80

100

-

-

-

-

-

-

11

7 (3+4)

T3a

T11^d

70

80

-

-

-

-

-

-

12

7 (3+4)

T3a

T12^d

50

90

-

-

-

-

-

-

13

9 (4+5)

T3a

T13^d

80

100

-

-

-

-

-

-

14

7 (3+4)

T3a

T14^d

65

90

-

-

-

-

N14-μD^e

T14-μD^e

15

7 (3+4)

T3a

T15^d

70

100

-

-

-

-

-

-

16

5 (2+3)

T2

T16^d

80

90

-

-

-

-

N16-μD^e

T16-μD^e

17

7 (3+4)

T3a

T17^d

80

95

-

-

-

-

-

-

18

8 (3+5)

T2

T18^d

65

95

-

-

-

-

-

-

19

6 (3+3)

T2

T19^d

70

90

-

-

-

-

-

-

20

7 (4+3)

T3a

T20^d

60

80

-

-

-

-

-

-

21

-

-

-

-

-

-

-

-

S2

-

-

22

-

-

-

-

-

-

-

-

S3

-

-

-

-

-

-

-

POOL N^d

45

0

-

-

-